Fractyl Health, Common Stock Performance
| GUTS Stock | 2.24 0.13 5.49% |
On a scale of 0 to 100, Fractyl Health, holds a performance score of 12. The firm shows a Beta (market volatility) of 1.63, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fractyl Health, will likely underperform. Please check Fractyl Health,'s value at risk, and the relationship between the standard deviation and kurtosis , to make a quick decision on whether Fractyl Health,'s price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Fractyl Health, Common are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Fractyl Health, unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (5.49) | Five Day Return (0.88) | Year To Date Return 5.16 | Ten Year Return (82.57) | All Time Return (82.57) |
1 | Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIPGLP-1 Gene Therapy Candidate for Obesity | 10/07/2025 |
2 | Fractyl Health Unveils Potent Preclinical Data for Dual GIPGLP-1 Gene Therapy RJVA-002 for Obesity | 10/17/2025 |
3 | Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025 | 11/05/2025 |
4 | Fractyl Health Reports Third Quarter 2025 Results Revita Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 20... | 11/12/2025 |
5 | Fractyl Health outlines 2026 Revita pivotal data and PMA submission targets as clinical momentum accelerates | 11/13/2025 |
6 | Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference | 12/01/2025 |
7 | Acquisition by Rajagopalan Harith of 10416 shares of Fractyl Health, at 1.92 subject to Rule 16b-3 | 12/04/2025 |
8 | Acquisition by Rajagopalan Harith of 2486302 shares of Fractyl Health, at 2.24 subject to Rule 16b-3 | 12/15/2025 |
9 | Fractyl Health, Inc. Receives 7.40 Consensus Target Price from Brokerages | 12/24/2025 |
| Begin Period Cash Flow | 37.8 M | |
| Total Cashflows From Investing Activities | -1.8 M | |
| Free Cash Flow | -67.3 M |
Fractyl Health, Relative Risk vs. Return Landscape
If you would invest 147.00 in Fractyl Health, Common on October 1, 2025 and sell it today you would earn a total of 77.00 from holding Fractyl Health, Common or generate 52.38% return on investment over 90 days. Fractyl Health, Common is currently generating 0.7813% in daily expected returns and assumes 4.8393% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Fractyl, and 85% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Fractyl Health, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fractyl Health,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Fractyl Health, Common, and traders can use it to determine the average amount a Fractyl Health,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1615
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GUTS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Fractyl Health, is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fractyl Health, by adding it to a well-diversified portfolio.
Fractyl Health, Fundamentals Growth
Fractyl Stock prices reflect investors' perceptions of the future prospects and financial health of Fractyl Health,, and Fractyl Health, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fractyl Stock performance.
| Return On Equity | -5.18 | ||||
| Return On Asset | -0.51 | ||||
| Current Valuation | 295.62 M | ||||
| Shares Outstanding | 137.04 M | ||||
| Price To Book | 1.86 X | ||||
| Price To Sales | 108,265 X | ||||
| Revenue | 93 K | ||||
| Gross Profit | 3 K | ||||
| EBITDA | (92.85 M) | ||||
| Net Income | (68.69 M) | ||||
| Total Debt | 62.5 M | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (65.52 M) | ||||
| Earnings Per Share | (2.32) X | ||||
| Market Capitalization | 324.8 M | ||||
| Total Asset | 108.08 M | ||||
| Retained Earnings | (415.31 M) | ||||
| Working Capital | 51.99 M | ||||
About Fractyl Health, Performance
Assessing Fractyl Health,'s fundamental ratios provides investors with valuable insights into Fractyl Health,'s financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Fractyl Health, is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 532.90 | 351.58 | |
| Return On Tangible Assets | (0.64) | (0.67) | |
| Return On Capital Employed | (1.06) | (1.11) | |
| Return On Assets | (0.64) | (0.67) | |
| Return On Equity | (2.42) | (2.30) |
Things to note about Fractyl Health, Common performance evaluation
Checking the ongoing alerts about Fractyl Health, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fractyl Health, Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fractyl Health, appears to be risky and price may revert if volatility continues | |
| Fractyl Health, has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 93 K. Net Loss for the year was (68.69 M) with profit before overhead, payroll, taxes, and interest of 3 K. | |
| Fractyl Health, generates negative cash flow from operations | |
| Fractyl Health, has a poor financial position based on the latest SEC disclosures | |
| About 75.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Fractyl Health, Inc. Receives 7.40 Consensus Target Price from Brokerages |
- Analyzing Fractyl Health,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fractyl Health,'s stock is overvalued or undervalued compared to its peers.
- Examining Fractyl Health,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fractyl Health,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fractyl Health,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fractyl Health,'s stock. These opinions can provide insight into Fractyl Health,'s potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Fractyl Stock Analysis
When running Fractyl Health,'s price analysis, check to measure Fractyl Health,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fractyl Health, is operating at the current time. Most of Fractyl Health,'s value examination focuses on studying past and present price action to predict the probability of Fractyl Health,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fractyl Health,'s price. Additionally, you may evaluate how the addition of Fractyl Health, to your portfolios can decrease your overall portfolio volatility.